Simplex Trading, LLC Mustang Bio, Inc. Transaction History

Simplex Trading, LLC

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Apr 27, 2023	BUY	$0.35 - $0.72 $3 - $7	10 New	10 $0
Q2 2022 Aug 03, 2022	SELL	$0.58 - $1.13 $1,484 - $2,892	-2,560 Reduced 98.69%	34 $0
Q1 2022 May 02, 2022	SELL	$0.73 - $1.81 $27,875 - $69,116	-38,186 Reduced 93.64%	2,594 $2,000
Q4 2021 Feb 23, 2022	BUY	$1.66 - $2.64 $52,610 - $83,669	31,693 Added 348.77%	40,780 $67,000
Q3 2021 Oct 28, 2021	SELL	$2.58 - $3.36 $46,917 - $61,101	-18,185 Reduced 66.68%	9,087 $30,000
Q2 2021 Aug 12, 2021	BUY	$2.7 - $3.81 $20,398 - $28,784	7,555 Added 38.32%	27,272 $90,000
Q1 2021 Apr 26, 2021	SELL	$3.02 - $5.16 $64,679 - $110,511	-21,417 Reduced 52.07%	19,717 $65,000
Q4 2020 Feb 02, 2021	BUY	$2.66 - $4.18 $60,959 - $95,793	22,917 Added 125.8%	41,134 $155,000
Q3 2020 Oct 14, 2020	BUY	$3.01 - $3.88 $54,152 - $69,805	17,991 Added 7960.62%	18,217 $57,000
Q2 2020 Jul 13, 2020	SELL	$2.33 - $4.6 $47,937 - $94,640	-20,574 Reduced 98.91%	226 $0
Q1 2020 Apr 29, 2020	BUY	$1.91 - $4.52 $39,728 - $94,015	20,800 New	20,800 $55,000
Q4 2019 Feb 05, 2020	SELL	$2.57 - $4.08 $2,413 - $3,831	-939 Closed	0 $0
Q3 2019 Oct 15, 2019	SELL	$2.74 - $4.65 $10,483 - $17,790	-3,826 Reduced 80.29%	939 $3,000
Q2 2019 Jul 26, 2019	BUY	$2.66 - $6.28 $12,674 - $29,924	4,765 New	4,765 $17,000

415K

Ticker MBIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 105,222,000
Market Cap $17.9M
Description
Mustang Bio, Inc., a clinical-stage biopharmaceutical company, focuses on translating medical breakthroughs in cell and gene therapies into potential cures for hematologic cancers, solid tumors, and rare genetic diseases. Its pipeline focuses on gene therapy programs for rare genetic disorders, chimeric antigen receptor (CAR) engineered T cell (...

Get notified when there are updates to the investment portfolio of Simplex Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Simplex Trading, LLC with notifications on news.